103 Views | 40 Downloads
Gerard Thomas Portela, Email: gtp14@pitt.edu
Dr Lilly Cheng Immergluck, Email: limmergluck@msm.edu
Guarantor - LCI. Study conception and design—LCI, SF, DS, SMR. Data acquisition—SF. Analysis and interpretation of results—AW, GTP, TL, AG, LCI, SF, SMR, DS. Draft manuscript preparation—GTP, LCI, SF. All authors reviewed the results and revised/approved the final version of the manuscript.
The authors would like to acknowledge the following individuals from Georgia EIP: Minerva Mendez and Amber Britton for the collection of non-invasive Staphylococcus aureus data; Shanita Shack for her work on geocoding all patients; Amy Tunali, Rahsaan Overton, and Stepy Thomas for their assistance with study design and data collection for invasive S. aureus.
Disclosure: None declared
Georgia Emerging Infections Program surveillance of invasive S. aureus was funded though the Centers for Disease Control and Prevention (CDC) Emerging Infections Program (grant number U50CK000485). Surveillance of non-invasive S. aureus was funded through an agreement between Pfizer and Emory University (grant number CP154653).
Research reported in this publication was supported in part by funds received (PHS Grant UL1TR002378) from the Clinical and Translational Science Award Program, National Institutes of Health, as part of the Georgia Clinical & Translational Science Alliance (Georgia CTSA) (formerly, UL1RR025008, Atlanta Clinical and Translational Science Institute (ACTSI)); Grant Number G12-RR03034, a component of the National Institute of Health; Grant Number HS024338-01; K-08 Mentored Clinical Scientist Award, Agency for Healthcare Research & Quality; and Grant Number G08LM013190-0, National Library of Medicine.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.